Acorda Therapeutics, Inc.
) was a big mover last session, as the company saw its shares
rise by roughly 8% on the day. The move came on solid volume too
with far more shares changing hands than in a normal
session. This continues the recent uptrend for the company
as the stock is now up almost 37% in the past one-month time
This biotechnology company has seen one positive estimate
revision and five negative estimate revisions over the last 30
days and its Zacks Consensus Estimate moved lower over the same
time frame, suggesting there may be trouble down the road. So
make sure to keep an eye on this stock going forward to see if
this recent move higher can last.
Acorda Therapeutics currently has a Zacks Rank #3 (Hold) while
Some better-ranked stocks in the same industry include
Alexion Pharmaceuticals, Inc.
Gilead Sciences Inc
). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days.
Click to get this free report >>
ACORDA THERAPT (ACOR): Free Stock Analysis
ALKERMES INC (ALKS): Free Stock Analysis
ALEXION PHARMA (ALXN): Free Stock Analysis
GILEAD SCIENCES (GILD): Free Stock Analysis
To read this article on Zacks.com click here.